BigHat Biosciences· BigHatBio·· 20 小时前AI 评分22
BigHat谈AI制药合作与LLM基准测试
Since day one, @BigHatBio has been a partner of choice to pharma for leveraging our lab in a loop to accelerate and overcome therapeutic ...
AI 导读
BigHat Biosciences称其自成立起即以“实验室闭环”方式与药企合作加速疗法研发，近期还与更广泛伙伴生成训练数据集、定制模型并基准测试LLM表现。CEO Peyton Greenside将于11月17日下午2点参加UBS会议AI药物发现专题讨论，并将在Jefferies医疗健康会议期间与CBO一同安排会面。
来源：BigHat Biosciences · x.com